These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 17013638)
1. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638 [TBL] [Abstract][Full Text] [Related]
2. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Halberstadt AL Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349 [TBL] [Abstract][Full Text] [Related]
3. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652 [TBL] [Abstract][Full Text] [Related]
5. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors. Riga MS; Bortolozzi A; Campa L; Artigas F; Celada P Neuropharmacology; 2016 Feb; 101():370-8. PubMed ID: 26477571 [TBL] [Abstract][Full Text] [Related]
6. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Halberstadt AL; Koedood L; Powell SB; Geyer MA J Psychopharmacol; 2011 Nov; 25(11):1548-61. PubMed ID: 21148021 [TBL] [Abstract][Full Text] [Related]
7. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT Riga MS; Lladó-Pelfort L; Artigas F; Celada P Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792 [TBL] [Abstract][Full Text] [Related]
8. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors. Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639 [TBL] [Abstract][Full Text] [Related]
9. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Ouagazzal A; Grottick AJ; Moreau J; Higgins GA Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors. Jiang XL; Shen HW; Yu AM Neuropharmacology; 2015 Feb; 89():342-51. PubMed ID: 25446678 [TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Halberstadt AL; Nichols DE; Geyer MA Psychopharmacology (Berl); 2012 Jun; 221(4):709-18. PubMed ID: 22222861 [TBL] [Abstract][Full Text] [Related]
12. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. van den Buuse M; Ruimschotel E; Martin S; Risbrough VB; Halberstadt AL Neuropharmacology; 2011; 61(1-2):209-16. PubMed ID: 21501627 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia. Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235 [TBL] [Abstract][Full Text] [Related]